For patients with coronary or ischemic heart disease or people at high heart attack risk (e.g., arrhythmias, hypertension, or diabetes mellitus), questions arise around the safety after COVID-19 vaccinations in the setting of increased ACE2 expression in the injured heart and warrant close investigation. Here, ACE2 is linked to myocardial infarction.